Firstly, repaglinide possesses cytotoxic effects against hepatic, breast and cervical carcinoma cells (HepG2, MCF-7 and HeLa cells) [35], or reduces the expression of Bcl-2, Beclin-1 and PD-L1 in glioma tissues [36]. This evidence concerns the gene BECN1 and cervical carcinoma.